Sunday, Nov 27, 2022

GSK Pharma Q1 net down 23 per cent at Rs 72.27 cr

The company had posted a net profit of Rs 94.01 crore for the same period year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

GSK pharma growth, gsk growth, glaxosmithkline growth, glaxo smith kline growth, gsk pharma, pharma news, pharma growth GSK Pharmaceuticals on July 28 reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter

GlaxoSmithKline Pharmaceuticals on July 28 reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter, on account of increase in expenditure.

The company had posted a net profit of Rs 94.01 crore for the same period year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

However, standalone total income from operations of the company rose to Rs 705.33 crore during the quarter as against Rs 651.70 crore in the corresponding period of the previous fiscal.

“Sales and net profit have been adversely impacted by government mandatory price cuts during the quarter,” the company said.

Subscriber Only Stories
JK Cement’s SPSU Udaipur Launches ‘Golden Batch 2022’ In Collaboration Wi...Premium
Appendicitis in Children- A new lifestyle disorderPremium
Using evidence will create strong foundations for the future of education...Premium
Re-Defining The Tradition In Folk Art: An Art Educator’s PerspectivePremium

Shares of GlaxoSmithKline Pharmaceuticals today closed 0.89 per cent down at Rs 3,347.50 per scrip on BSE.

First published on: 28-07-2016 at 04:59:43 pm
Next Story

Happy Birthday Dhanush: He is the face Bollywood desperately needs today

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement